Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,148 | 1 | 66.6% |
| Food and Beverage | $1,077 | 19 | 33.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,552 | 6 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $234.25 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $203.90 | 4 | $0 (2017) |
| Phadia US Inc. | $97.76 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $88.58 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.60 | 2 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $16.55 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $89.10 | 1 | AstraZeneca Pharmaceuticals LP ($89.10) |
| 2022 | $293.91 | 6 | AstraZeneca Pharmaceuticals LP ($163.55) |
| 2021 | $2,148 | 1 | AstraZeneca Pharmaceuticals LP ($2,148) |
| 2019 | $113.52 | 1 | Teva Pharmaceuticals USA, Inc. ($113.52) |
| 2018 | $328.68 | 5 | Teva Pharmaceuticals USA, Inc. ($120.73) |
| 2017 | $251.95 | 6 | GlaxoSmithKline, LLC. ($203.90) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/27/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $89.10 | General |
| 10/16/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $34.72 | General |
| 10/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $76.27 | General |
| Category: Allergy/Immunology | ||||||
| 08/05/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $21.49 | General |
| Category: Allergy/Immunology | ||||||
| 05/06/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $128.83 | General |
| 04/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| 10/09/2019 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $113.52 | General |
| Category: Respiratory | ||||||
| 10/17/2018 | Merck Sharp & Dohme Corporation | DULERA (Drug) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $119.37 | General |
| Category: Respiratory | ||||||
| 09/05/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/23/2018 | Merck Sharp & Dohme Corporation | DULERA (Drug) | Food and Beverage | In-kind items and services | $39.61 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2018 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Drug) | Food and Beverage | In-kind items and services | $120.73 | General |
| Category: Respiratory | ||||||
| 10/18/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological), BREO, ANORO | Food and Beverage | In-kind items and services | $76.96 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.50 | General |
| 06/28/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BRONCHIAL THERMOPLASTY (Device) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: BRONCHIAL THERMOPLASTY | ||||||
| 01/31/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $95.28 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 25 | $12,558 | $1,717 |
| 2022 | 6 | 159 | 246 | $204,668 | $29,089 |
| 2021 | 6 | 165 | 255 | $218,164 | $30,437 |
| 2020 | 5 | 172 | 282 | $250,724 | $32,218 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 14 | $8,189 | $1,118 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $4,369 | $598.64 | 13.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 26 | 81 | $122,148 | $13,847 | 11.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 36 | 47 | $25,053 | $4,989 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 66 | $24,750 | $4,743 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $11,476 | $2,146 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $9,628 | $1,689 | 17.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 21 | $11,613 | $1,675 | 14.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 41 | 97 | $146,276 | $17,109 | 11.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 42 | 55 | $28,550 | $5,773 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 40 | 53 | $19,445 | $3,573 | 18.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 24 | $12,888 | $1,964 | 15.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $8,188 | $1,526 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 12 | $2,817 | $491.58 | 17.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 47 | 115 | $173,420 | $20,347 | 11.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 55 | $28,655 | $4,540 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 44 | 58 | $20,752 | $3,071 | 14.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 34 | 40 | $20,225 | $3,013 | 14.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 14 | 14 | $7,672 | $1,248 | 16.3% |
About Sumita Khatri, MD, MS
Sumita Khatri, MD, MS is a Internal Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508899329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sumita Khatri, MD, MS has received a total of $3,225 in payments from pharmaceutical and medical device companies, with $89.10 received in 2023. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($2,148).
As a Medicare-enrolled provider, Khatri has provided services to 521 Medicare beneficiaries, totaling 808 services with total Medicare billing of $93,461. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cleveland, OH
- Active Since 07/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508899329
Products in Payments
- NUCALA (Biological) $172.24
- CINQAIR (Drug) $120.73
- FASENRA (Drug) $119.37
- PROAIR (Drug) $113.52
- ImmunoCAP (Device) $97.76
- DULERA (Drug) $71.21
- STIOLTO RESPIMAT (Drug) $32.60
- BREO (Drug) $18.14
- ZERBAXA (Drug) $17.37
- GENERAL - BRONCHIAL THERMOPLASTY (Device) $16.55
- ANORO (Drug) $13.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cleveland
C Martin Harris, Md, MD
Internal Medicine — Payments: $1.1M
Marina Magrey, Md, MD
Internal Medicine — Payments: $491,321
Dr. Moshe Ornstein, Md Ma, MD MA
Internal Medicine — Payments: $250,140
Dr. Katherine Talcott, M.d, M.D
Internal Medicine — Payments: $248,994
Dr. Elliott Dasenbrook, Md, MD
Internal Medicine — Payments: $184,924
Syed Bukhari
Internal Medicine — Payments: $164,516